Business Description
Sernova Biotherapeutics Inc
NAICS : 541710
SIC : 3741
ISIN : CA81732W1041
Total Employee Number:
8Description
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.43 | |||||
Equity-to-Asset | -6.28 | |||||
Debt-to-Equity | -0.25 | |||||
Debt-to-EBITDA | -0.25 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 19.7 | |||||
3-Year EPS without NRI Growth Rate | 17.8 | |||||
3-Year FCF Growth Rate | 15.1 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.5 | |||||
9-Day RSI | 42.77 | |||||
14-Day RSI | 43.41 | |||||
3-1 Month Momentum % | -6.88 | |||||
6-1 Month Momentum % | 14.16 | |||||
12-1 Month Momentum % | -4.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.14 | |||||
Quick Ratio | 0.14 | |||||
Cash Ratio | 0.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | -17.32 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -730.79 | |||||
ROIC % | -116.03 | |||||
3-Year ROIIC % | 65.11 | |||||
ROC (Joel Greenblatt) % | -5310.56 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -6.53 | |||||
EV-to-Forward-EBIT | -1.39 | |||||
EV-to-EBITDA | -6.7 | |||||
EV-to-Forward-EBITDA | -1.39 | |||||
EV-to-FCF | -12.14 | |||||
Earnings Yield (Greenblatt) % | -15.31 | |||||
FCF Yield % | -10.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SEOVF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sernova Biotherapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.028 | ||
| Beta | 0.3176 | ||
| 3-Year Sharpe Ratio | -1.06 | ||
| 3-Year Sortino Ratio | -1.39 | ||
| Volatility % | 56.76 | ||
| 14-Day RSI | 43.41 | ||
| 14-Day ATR ($) | 0.011262 | ||
| 20-Day SMA ($) | 0.109469 | ||
| 12-1 Month Momentum % | -4.65 | ||
| 52-Week Range ($) | 0.06838 - 0.1567 | ||
| Shares Outstanding (Mil) | 377.64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sernova Biotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sernova Biotherapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sernova Biotherapeutics Inc Frequently Asked Questions
What is Sernova Biotherapeutics Inc(SEOVF)'s stock price today?
The current price of SEOVF is $0.10. The 52 week high of SEOVF is $0.16 and 52 week low is $0.07.
When is next earnings date of Sernova Biotherapeutics Inc(SEOVF)?
The next earnings date of Sernova Biotherapeutics Inc(SEOVF) is .
Does Sernova Biotherapeutics Inc(SEOVF) pay dividends? If so, how much?
Sernova Biotherapeutics Inc(SEOVF) does not pay dividend.
Guru Commentaries on OTCPK:SEOVF
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| Sernova Announces Biotech Veteran as New Chief Financial Officer | 2019-10-24 |
Articles on Sernova Biotherapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers